Ramos, Edneia A S <br/><br/>
Worse prognosis in breast cancer patients can be predicted by immunohistochemical analysis of positive MMP-2 and negative estrogen and progesterone receptors.  [electronic resource] 

 -  Revista da Associacao Medica Brasileira (1992)  Nov 2016 
 - 774-781 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1806-9282 
<br/><br/><label>Standard No.: </label>10.1590/1806-9282.62.08.774  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Biomarkers, Tumor--analysis<br/>Brazil--epidemiology<br/>Breast Neoplasms--chemistry<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>Matrix Metalloproteinase 2--analysis<br/>Middle Aged<br/>Neoplasm Grading<br/>Neoplasm Metastasis<br/>Neoplasm Staging<br/>Prognosis<br/>Receptors, Estrogen--analysis<br/>Receptors, Progesterone--analysis